Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing

RNA Biology

Volumn 11, Issue 10, 2014, Pages 1233-1237

  Fossat, Nicolas ^a,b   Tam, Patrick P L ^a,b  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

A1CF; APOBEC1; Apolipoprotein b; Intestine; RBM47; RNA editing

Indexed keywords

A1CF PROTEIN; APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CYTIDINE; MESSENGER RNA; UNCLASSIFIED DRUG; URIDINE; APOLIPOPROTEIN B MRNA EDITING ENZYME; CYTIDINE DEAMINASE;

GENE; GENE EXPRESSION; NONHUMAN; RBM47 GENE; REVIEW; RNA EDITING; RNA TRANSLATION; ANIMAL; HUMAN; METABOLISM;

ANIMALS; APOLIPOPROTEINS B; CYTIDINE; CYTIDINE DEAMINASE; HUMANS; RNA EDITING; RNA, MESSENGER; URIDINE;

EID: 84921867216     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2014.996054     Document Type: Review

References (50)

1. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987; 238:363-6; PMID:3659919; http://dx.doi.org/10.1126/science.3659919
2. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 1987; 50:831-40; PMID:3621347; http://dx.doi.org/10.1016/0092-8674(87)90510-1
3. Teng B, Burant CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 1993; 260:1816-9; PMID:8511591; http://dx.doi.org/10.1126/science.8511591
4. Navaratnam N, Morrison JR, Bhattacharya S, Patel D, Funahashi T, Giannoni F, Teng BB, Davidson NO, Scott J. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem 1993; 268:20709-12; PMID:8407891
5. Hadjiagapiou C, Giannoni F, Funahashi T, Skarosi SF, Davidson NO. Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein. Nucleic Acids Res 1994; 22:1874-9; PMID:8208612; http://dx.doi.org/10.1093/nar/22.10.1874
6. Hirano K, Young SG, Farese RV Jr., Ng J, Sande E, Warburton C, Powell-Braxton LM, Davidson NO. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 1996; 271:9887-90; PMID:8626621; http://dx.doi.org/10.1074/jbc.271.1.380
7. Morrison JR, Paszty C, Stevens ME, Hughes SD, Forte T, Scott J, Rubin EM. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc Natl Acad Sci U S A 1996; 93:7154-9; PMID:8692961; http://dx.doi.org/10.1073/pnas.93.14.7154
8. Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, Oka K, Li E, Chan L. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J Biol Chem 1996; 271:25981-8; PMID:8824235; http://dx.doi.org/10.1074/jbc.271.42.25981
9. Sowden MP, Ballatori N, Jensen KL, Reed LH, Smith HC. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. J Cell Sci 2002; 115:1027-39; PMID:11870221
10. Blanc V, Davidson NO. APOBEC-1-mediated RNA editing. Wiley Interdiscip Rev Syst Biol Med 2010; 2:594-602; PMID:20836050; http://dx.doi.org/10.1002/wsbm.82
11. Mehta A, Banerjee S, Driscoll DM. Apobec-1 interacts with a 65-kDa complementing protein to edit apolipoprotein-B mRNA in vitro. J Biol Chem 1996; 271:28294-9; PMID:8910449; http://dx.doi.org/10.1074/jbc.271.45.28294
12. Mehta A, Kinter MT, Sherman NE, Driscoll DM. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 2000; 20:1846-54; PMID:10669759; http://dx.doi.org/10.1128/MCB.20.5.1846-1854.2000
13. Lellek H, Kirsten R, Diehl I, Apostel F, Buck F, Greeve J. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem 2000; 275:19848-56; PMID:10781591; http://dx.doi.org/10.1074/jbc.M001786200
14. Henderson JO, Blanc V, Davidson NO. Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. Biochim Biophys Acta 2001; 1522:22-30; PMID:11718896; http://dx.doi.org/10.1016/S0167-4781(01)00295-0
15. Blanc V, Navaratnam N, Henderson JO, Anant S, Kennedy S, Jarmuz A, Scott J, Davidson NO. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing. J Biol Chem 2001; 276:10272-83; PMID:11134005; http://dx.doi.org/10.1074/jbc.M006435200
16. Anant S, Henderson JO, Mukhopadhyay D, Navaratnam N, Kennedy S, Min J, Davidson NO. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem 2001; 276:47338-51; PMID:11577082; http://dx.doi.org/10.1074/jbc.M104911200
17. Fossat N, Tourle K, Radziewic T, Barratt K, Liebhold D, Studdert JB, Power M, Jones V, Loebel DA, Tam PP. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47. EMBO Rep 2014; 15:903-10; PMID:24916387; http://dx.doi.org/10.15252/embr.201438450
18. Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3′ UTRs. Nat Struct Mol Biol 2011; 18:230-6; PMID:21258325; http://dx.doi.org/10.1038/nsmb.1975
19. Blanc V, Park E, Schaefer S, Miller M, Lin Y, Kennedy S, Billing AM, Ben Hamidane H, Graumann J, Mortazavi A, et al. Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver. Genome Biol 2014; 15:R79; PMID:24946870; http://dx.doi.org/10.1186/gb-2014-15-6-r79
20. Loebel DA, Studdert JB, Power M, Radziewic T, Jones V, Coultas L, Jackson Y, Rao RS, Steiner K, Fossat N, et al. Rhou maintains the epithelial architecture and facilitates differentiation of the foregut endoderm. Development 2011; 138:4511-22; PMID:21903671; http://dx.doi.org/10.1242/dev.063867
21. Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, et al. Ensembl 2013. Nucleic Acids Res 2013; 41:D48-55; PMID:23203987; http://dx.doi.org/10.1093/nar/gks1236
22. Lau PP, Xiong WJ, Zhu HJ, Chen SH, Chan L. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J Biol Chem 1991; 266:20550-4; PMID:1939106
23. Lau PP, Zhu HJ, Nakamuta M, Chan L. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J Biol Chem 1997; 272:1452-5; PMID:8999813; http://dx.doi.org/10.1074/jbc.272.3.1452
24. Lau PP, Chang BH, Chan L. Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome. Biochem Biophys Res Commun 2001; 282:977-83; PMID:11352648; http://dx.doi.org/10.1006/bbrc.2001.4679
25. Greeve J, Lellek H, Rautenberg P, Greten H. Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes. Biol Chem 1998; 379:1063-73; PMID:9792439; http://dx.doi.org/10.1515/bchm.1998.379.8-9.1063
26. Lau PP, Villanueva H, Kobayashi K, Nakamuta M, Chang BH, Chan L. A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J Biol Chem 2001; 276:46445-52; PMID:11584023; http://dx.doi.org/10.1074/jbc.M109215200
27. Lau PP, Chan L. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing. J Biol Chem 2003; 278:52988-96; PMID:14559896; http://dx.doi.org/10.1074/jbc.M310153200
28. Chen Z, Eggerman TL, Patterson AP. ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components. Am J Physiol Gastrointest Liver Physiol 2007; 292:G53-65; PMID:16920700; http://dx.doi.org/10.1152/ajpgi.00118.2006
29. Blanc V, Henderson JO, Newberry EP, Kennedy S, Luo J, Davidson NO. Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality. Mol Cell Biol 2005; 25:7260-9; PMID:16055734; http://dx.doi.org/10.1128/MCB.25.16.7260-7269.2005
30. Bhattacharya C, Aggarwal S, Kumar M, Ali A, Matin A. Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1). PLoS One 2008; 3:e2315; PMID:18509452; http://dx.doi.org/10.1371/journal.pone.0002315
31. Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML, Lamb BT, Deng JM, Behringer RR, Capel B, et al. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 2005; 435:360-4; PMID:15902260; http://dx.doi.org/10.1038/nature03595
32. Nelson VR, Heaney JD, Tesar PJ, Davidson NO, Nadeau JH. Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability. Proc Natl Acad Sci U S A 2012; 109:E2766-73; PMID:22923694; http://dx.doi.org/10.1073/pnas.1207169109
33. Prohaska KM, Bennett RP, Salter JD, Smith HC. The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions. Wiley Interdiscip Rev RNA 2014; 5:493-508; PMID:24664896; http://dx.doi.org/10.1002/wrna.1226
34. Smith HC, Bennett RP, Kizilyer A, McDougall WM, Prohaska KM. Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol 2012; 23:258-68; PMID:22001110; http://dx.doi.org/10.1016/j.semcdb.2011.10.004
35. Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 2006; 281:29105-19; PMID:16887808; http://dx.doi.org/10.1074/jbc.M601901200
36. Gallois-Montbrun S, Holmes RK, Swanson CM, Fernandez-Ocana M, Byers HL, Ward MA, Malim MH. Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J Virol 2008; 82:5636-42; PMID:18367521; http://dx.doi.org/10.1128/JVI.00287-08
37. Ali S, Karki N, Bhattacharya C, Zhu R, MacDuff DA, Stenglein MD, Schumacher AJ, Demorest ZL, Harris RS, Matin A, et al. APOBEC3 inhibits DEAD-END function to regulate microRNA activity. BMC Mol Biol 2013; 14:16; PMID:23890083; http://dx.doi.org/10.1186/1471-2199-14-16
38. Yamanaka S, Poksay KS, Arnold KS, Innerarity TL. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev 1997; 11:321-33; PMID:9030685; http://dx.doi.org/10.1101/gad.11.3.321
39. Mukhopadhyay D, Anant S, Lee RM, Kennedy S, Viskochil D, Davidson NO. C->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. Am J Hum Genet 2002; 70:38-50; PMID:11727199; http://dx.doi.org/10.1086/337952
40. Sniderman A, Couture P, de Graaf J. Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. Nat Rev Endocrinol 2010; 6:335-46; PMID:20421882; http://dx.doi.org/10.1038/nrendo.2010.50
41. Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D. Patterns of variant polyadenylation signal usage in human genes. Genome Res 2000; 10:1001-10; PMID:10899149; http://dx.doi.org/10.1101/gr.10.7.1001
42. Anant S, Murmu N, Houchen CW, Mukhopadhyay D, Riehl TE, Young SG, Morrison AR, Stenson WF, Davidson NO. Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 2004; 127:1139-49; PMID:15480992; http://dx.doi.org/10.1053/j.gastro.2004.06.022
43. Shimizu Y, Nishitsuji H, Marusawa H, Ujino S, Takaku H, Shimotohno K. The RNA-editing Enzyme APOBEC1 Requires Heterogeneous Nuclear Ribonucleoprotein Q Isoform 6 for Efficient Interaction with Interleukin 8 mRNA. J Biol Chem 2014; 289:26226-38; PMID:25100733; http://dx.doi.org/10.1074/jbc.M114.563221
44. Blanc V, Henderson JO, Newberry RD, Xie Y, Cho SJ, Newberry EP, Kennedy S, Rubin DC, Wang HL, Luo J, et al. Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice. Cancer Res 2007; 67:8565-73; PMID:17875695; http://dx.doi.org/10.1158/0008-5472.CAN-07-1593
45. Xie Y, Blanc V, Kerr TA, Kennedy S, Luo J, Newberry EP, Davidson NO. Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility. J Biol Chem 2009; 284:16860-71; PMID:19386592; http://dx.doi.org/10.1074/jbc.M109.010173
46. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 2003; 11:113-26; PMID:12535526; http://dx.doi.org/10.1016/S1097-2765(03)00012-1
47. Sureban SM, Murmu N, Rodriguez P, May R, Maheshwari R, Dieckgraefe BK, Houchen CW, Anant S. Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation. Gastroenterology 2007; 132:1055-65; PMID:17383427; http://dx.doi.org/10.1053/j.gastro.2006.12.031
48. Vanharanta S, Marney CB, Shu W, Valiente M, Zou Y, Mele A, Darnell RB, Massague J. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. Elife 2014; 3:e02734; PMID:24898756; http://dx.doi.org/10.7554/eLife.02734
49. Mallela A, Nishikura K. A-to-I editing of protein coding and noncoding RNAs. Crit Rev Biochem Mol Biol 2012; 47:493-501; PMID:22988838; http://dx.doi.org/10.3109/10409238.2012.714350
50. Avesson L, Barry G. The emerging role of RNA and DNA editing in cancer. Biochim Biophys Acta 2014; 1845:308-16; PMID:24607277